Stanford Medicine May 8, 2019

Years-long tracking of individuals’ biology helped define what it meant for them to be healthy and showed how changes from the norm could signal disease, a Stanford-led study reports.

Scientists at the Stanford University School of Medicine and their collaborators followed a cohort of more than 100 people over several years, tracking the biology of what makes them them. Now, after collecting extensive data on the group’s genetic and molecular makeup, the researchers are piecing together a new understanding of what it means to be healthy and how deviations from an individual’s norm can flag early signs of disease.

The results point to a need for a paradigm shift, said Michael Snyder, PhD, professor and chair of genetics.

“I would...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Big Data, Biotechnology, Market Research, Precision Medicine, Technology, Trends
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article